Abstract:Juvenile-onset recurrent respiratory papillomatosis (JoRRP) is driven by human papillomavirus (HPV) low-risk strains and is associated with significant morbidity. While previous studies of 2D cultures have shed light on disease pathogenesis and demonstrated the utility of personalized medicine approaches, monolayer cultures lack the 3D tissue architecture and physiology of stratified, sequentially differentiated mucosal epithelium important in RRP disease pathogenesis. Herein we describe the establishment of J… Show more
“…Proliferation index increased to a median of 3.4% in diseased murine laryngeal tissues, and Ki67-expressing cells were found above the basal layer of the epithelium. A similar expansion of proliferating cells has been observed in RRP lesions [ 23 ] and in MmuPV1-induced lesions of the oral cavity and the anogenital tract [ 74 , 75 , 76 , 77 ]. Like the larynx, we found that proliferation and hyperplasia increased in trachea with MmuPV1-induced disease.…”
Section: Discussionsupporting
confidence: 72%
“…Healthy vocal fold epithelium is characterized by proliferating cells in the basal and parabasal layers and differentiated suprabasal cells [ 20 , 21 , 22 ]. Human RRP lesions are characterized by an expanded basal compartment, proliferating cells throughout epithelial layers, and decreased differentiation [ 23 , 24 , 25 , 26 , 27 ]. High-risk HPVs are known to suppress apoptosis in infected cells [ 28 ], and apoptosis may play a role in vocal fold epithelial diseases [ 29 ].…”
Laryngeal infection with low-risk human papillomaviruses can cause recurrent respiratory papillomatosis (RRP), a disease with severe effects on vocal fold epithelium resulting in impaired voice function and communication. RRP research has been stymied by limited preclinical models. We recently reported a murine model of laryngeal MmuPV1 infection and disease in immunodeficient mice. In the current study, we compare quantitative and qualitative measures of epithelial proliferation, apoptosis, differentiation, and barrier between mice with MmuPV1-induced disease of the larynx and surrounding tissues and equal numbers of uninfected controls. Findings supported our hypothesis that laryngeal MmuPV1 infection recapitulates many features of RRP. Like RRP, MmuPV1 increased proliferation in infected vocal fold epithelium, expanded the basal compartment of cells, decreased differentiated cells, and altered cell–cell junctions and basement membrane. Effects of MmuPV1 on apoptosis were equivocal, as with RRP. Barrier markers resembled human neoplastic disease in severe MmuPV1-induced disease. We conclude that MmuPV1 infection of the mouse larynx provides a useful, if imperfect, preclinical model for RRP that will facilitate further study and treatment development for this intractable and devastating disease.
“…Proliferation index increased to a median of 3.4% in diseased murine laryngeal tissues, and Ki67-expressing cells were found above the basal layer of the epithelium. A similar expansion of proliferating cells has been observed in RRP lesions [ 23 ] and in MmuPV1-induced lesions of the oral cavity and the anogenital tract [ 74 , 75 , 76 , 77 ]. Like the larynx, we found that proliferation and hyperplasia increased in trachea with MmuPV1-induced disease.…”
Section: Discussionsupporting
confidence: 72%
“…Healthy vocal fold epithelium is characterized by proliferating cells in the basal and parabasal layers and differentiated suprabasal cells [ 20 , 21 , 22 ]. Human RRP lesions are characterized by an expanded basal compartment, proliferating cells throughout epithelial layers, and decreased differentiation [ 23 , 24 , 25 , 26 , 27 ]. High-risk HPVs are known to suppress apoptosis in infected cells [ 28 ], and apoptosis may play a role in vocal fold epithelial diseases [ 29 ].…”
Laryngeal infection with low-risk human papillomaviruses can cause recurrent respiratory papillomatosis (RRP), a disease with severe effects on vocal fold epithelium resulting in impaired voice function and communication. RRP research has been stymied by limited preclinical models. We recently reported a murine model of laryngeal MmuPV1 infection and disease in immunodeficient mice. In the current study, we compare quantitative and qualitative measures of epithelial proliferation, apoptosis, differentiation, and barrier between mice with MmuPV1-induced disease of the larynx and surrounding tissues and equal numbers of uninfected controls. Findings supported our hypothesis that laryngeal MmuPV1 infection recapitulates many features of RRP. Like RRP, MmuPV1 increased proliferation in infected vocal fold epithelium, expanded the basal compartment of cells, decreased differentiated cells, and altered cell–cell junctions and basement membrane. Effects of MmuPV1 on apoptosis were equivocal, as with RRP. Barrier markers resembled human neoplastic disease in severe MmuPV1-induced disease. We conclude that MmuPV1 infection of the mouse larynx provides a useful, if imperfect, preclinical model for RRP that will facilitate further study and treatment development for this intractable and devastating disease.
“…Models of low-risk HPV-associated diseases, including RRP, are limited [ 41 ]. Current preclinical models of RRP are limited to in vitro organotypic raft culture and xenografts, which are typically used at early passages to study short-term viral and host gene expression [ 42 , 43 , 44 , 45 ]. In the sole reported experimental infection of an animal larynx with an animal papillomavirus, canine oral papillomavirus (COPV) was injected into the supraglottic laryngeal tissues of canines [ 46 ].…”
Recurrent respiratory papillomatosis (RRP), caused by laryngeal infection with low-risk human papillomaviruses, has devastating effects on vocal communication and quality of life. Factors in RRP onset, other than viral presence in the airway, are poorly understood. RRP research has been stalled by limited preclinical models. The only known papillomavirus able to infect laboratory mice, Mus musculus papillomavirus (MmuPV1), induces disease in a variety of tissues. We hypothesized that MmuPV1 could infect the larynx as a foundation for a preclinical model of RRP. We further hypothesized that epithelial injury would enhance the ability of MmuPV1 to cause laryngeal disease, because injury is a potential factor in RRP and promotes MmuPV1 infection in other tissues. In this report, we infected larynges of NOD scid gamma mice with MmuPV1 with and without vocal fold abrasion and measured infection and disease pathogenesis over 12 weeks. Laryngeal disease incidence and severity increased earlier in mice that underwent injury in addition to infection. However, laryngeal disease emerged in all infected mice by week 12, with or without injury. Secondary laryngeal infections and disease arose in nude mice after MmuPV1 skin infections, confirming that experimentally induced injury is dispensable for laryngeal MmuPV1 infection and disease in immunocompromised mice. Unlike RRP, lesions were relatively flat dysplasias and they could progress to cancer. Similar to RRP, MmuPV1 transcript was detected in all laryngeal disease and in clinically normal larynges. MmuPV1 capsid protein was largely absent from the larynx, but productive infection arose in a case of squamous metaplasia at the level of the cricoid cartilage. Similar to RRP, disease spread beyond the larynx to the trachea and bronchi. This first report of laryngeal MmuPV1 infection provides a foundation for a preclinical model of RRP.
“…Biopsies were obtained and used to establish primary mucosal squamous epithelial cell cultures as previously described [ 36 ]. Importantly, matched biopsy sets of papilloma and non-diseased tissue were obtained per patient.…”
Section: Methodsmentioning
confidence: 99%
“…2D cell pellets were collected from early passage (passage 2–4) primary cells derived from papilloma biopsies, extracted for RNA, and run by RT-qPCR using HPV-strain specific primers to determine HPV6 versus HPV11 genotype as previously described [ 36 ].…”
Juvenile-onset recurrent respiratory papillomatosis (JoRRP) is the most common benign neoplasm of the larynx in children, presenting with significant variation in clinical course and potential for progression to malignancy. Since JoRRP is driven by human papillomavirus (HPV), we evaluated viral factors in a prospective cohort to identify predictive factors of disease severity. Twenty children with JoRRP undergoing routine debridement of papillomas were recruited and followed for ≥1 year. Demographical features, clinical severity scores, and surgeries over time were tabulated. Biopsies were used to establish a tissue bank and primary cell cultures for HPV6 vs. HPV11 genotyping and evaluation of viral gene expression. We found that patients with HPV11+ disease had an earlier age at disease onset, higher frequency of surgeries, increased number of lifetime surgeries, and were more likely to progress to malignancy. However, the amplitude of viral E6/E7 gene expression did not account for increased disease severity in HPV11+ patients. Determination of HPV strain is not routinely performed in the standard of care for JoRRP patients; we demonstrate the utility and feasibility of HPV genotyping using RNA-ISH for screening of HPV11+ disease as a biomarker for disease severity and progression in JoRRP patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.